Interv Akut Kardiol. 2006;5(6):250-253

IATROGENIC PERFORATION OF CORONARY ARTERY

David Horák, MUDr. František Holm CSc
Kardiologické oddělení, Krajská nemocnice Liberec

Iatrogenic coronary perforation is rare, but life threatening complication of intracoronary procedures. Beside pharmacological and surgical interventions there are endovascular procedures including stengraft and coil implantation. Some data suggest that stent-graft implantation is in type III perforation superior to prolonged balloon inflations as a first line therapy reduces need for surgery and possibly death rate.

Keywords: Keywords: perforation, stentgraft, tamponade, percutaneous interventions.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horák D, Holm F. IATROGENIC PERFORATION OF CORONARY ARTERY. Interv Akut Kardiol. 2006;5(6):250-253.
Download citation

References

  1. Ellis SG et al. Increased coronary perforation in the new device era. Incidence, classification, management and outcome. Circulation 1994; 90: 2725-2730. Go to original source... Go to PubMed...
  2. Dippel EJ et al. Coronary perforation during percutaneous coronary perforation in the era of abciximab platelet IIb/IIIa blockade: an algorithm for percutaneous management, Cathet Cardiovasc Intervention 2001; 52:279-286. Go to original source... Go to PubMed...
  3. Gruberg L et al. Incidence, management and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2000; 86:680-682. Go to original source... Go to PubMed...
  4. Iannone LA. Iatrogenic left coronary artery fistula-to-left ventricle following PTCA:A previously unreported complication with nonsurgical treatment. Am Heart J. 1990; 120:1215-1217. Go to original source... Go to PubMed...
  5. Holmes et. al. Coronary perforation after excimer laser angioplasty registry experience. J Am Coll Cardiol 1994;23:330-335. Go to original source... Go to PubMed...
  6. Ajuni SC. Perforation after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations. Cathet Cardiovasc Diagn. 1994; 32:206-212. Go to original source... Go to PubMed...
  7. Bittl JA. Coronary artery perforation during excimer laser angioplasty. J Am Coll Cardiol 1993; 21: 1158-1165. Go to original source... Go to PubMed...
  8. Briguori C et al. Emergency Polyte.trafluoretylen-Covered Stent Implantation to Treat Coronary Ruptures. Circulation 2000; 102:3028-3031. Go to original source... Go to PubMed...
  9. Briguori C et.al. Administration of Protamine After Coronary Stent Deployment. Am Heart J 1999;138:64-68. Go to original source... Go to PubMed...
  10. Ducas J et al. Immediate protamine administration and sheath removal following percutaneous coronary intervention: A prospective study of 429 patients. Catheter. cardiovasc. Interv, 2002, vol. 56, no2, pp. 196-199 (18 ref.). Go to original source... Go to PubMed...
  11. Guidelines for Percutaneous Coronary Interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. European Heart Journal 2005; 26:804-847. Go to original source... Go to PubMed...
  12. Khambekar SK, Hubner PJ. Immediate Femoral Sheath Removal After Angioplasty Following Heparin Reversal with Protamine, Poster No 341 at TCT 2003.
  13. Chou E, Minutello RM et al. Improved Treatment Outcomes with PTFE-Covered Stents in Patients with Iatrogenic Coronary perforation. Poster No 370 at TCT 2004.
  14. Bonello L, Paule P et al. An unusual mid term complication of coronary rupture. Int J Cardiol. 2005; 104(1):119-21. Go to original source... Go to PubMed...
  15. Dixon SR, Webster MWI et al. Gelfoam embolization of a distal coronary artery guidwire perforation. Cathet Cardiovasc Intervent 2000; 49:214-217. Go to original source...
  16. Grines CL, Savu MA, Tejada LA, Interventional Cardiology, The Essentials For The Boards, Futura Publishing Company, Inc. Armonk NY 1999.
  17. The Japanese Perforation and IVUS Registry in Stenting; CCT 2005 Kobe, Department of Cardiology, Heart Center, Rinku General Medical Center, Osaka, Nojima Yuhei et al.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.